Search

Your search keyword '"Terada, Mari"' showing total 192 results

Search Constraints

Start Over You searched for: Author "Terada, Mari" Remove constraint Author: "Terada, Mari"
192 results on '"Terada, Mari"'

Search Results

4. Trends of participants in convalescent plasma donation for COVID-19 in Japan as the pandemic evolved

5. Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial

9. Effectiveness of Favipiravir on Nonsevere, Early-Stage COVID-19 in Japan: A Large Observational Study Using the COVID-19 Registry Japan

11. Clinical characteristics of the first three waves of hospitalised patients with COVID-19 in Japan prior to the widespread use of vaccination: a nationwide observational study

12. Effectiveness of remdesivir in hospitalized nonsevere patients with COVID-19 in Japan: A large observational study using the COVID-19 Registry Japan

15. Fatty liver on computed tomography scan on admission is a risk factor for severe coronavirus disease

16. Factors associated with high antibody titer following coronavirus disease among 581 convalescent plasma donors: A single-center cross-sectional study in Japan

17. Evaluation of the efficacy of anticoagulation therapy in reducing mortality in a nationwide cohort of hospitalized patients with coronavirus disease in Japan

20. External validation and update of prediction models for unfavorable outcomes in hospitalized patients with COVID-19 in Japan

23. Efficacy and Safety of Treatment with Plasma from COVID-19-Recovered Individuals

28. We Should Pay More Attention to Sex Differences to Predict the Risk of Severe COVID-19: Men Have the Same Risk of Worse Prognosis as Women More Than 10 Years Older

31. Preserved SARS-CoV-2 neutralizing IgG activity of in-house manufactured COVID-19 convalescent plasma

32. Evaluation of the representativeness of data in the COVID-19 Registry Japan during the first six waves of the epidemic

33. Renin-angiotensin system blocker and the COVID-19 aggravation in patients with hypertension, diabetes, renal failure, Cerebro-cardiovascular disease, or pulmonary disease: Report by the COVID-19 Registry Japan

34. Predictive model of risk factors of High Flow Nasal Cannula using machine learning in COVID-19

35. Safety of convalescent plasma therapy for COVID-19 patients and analysis of viral kinetics: a single-center, open-label, single-arm, interventional study in Japan

36. Evaluation of the Detection of Pathogens in Hospitalized Patients with COVID-19 at a Tertiary Hospital in Japan

39. A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT)

41. Post COVID-19 condition of the Omicron variant of SARS-CoV-2

42. A nationwide prospective cohort study on safety of the 17D-204 yellow fever vaccine during a vaccine shortage in Japan.

43. Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection

45. Comorbidities as Risk Factors for Severe Disease in Hospitalized Elderly COVID-19 Patients by Different Age-Groups in Japan

46. Smoking and severe illness in hospitalized COVID-19 patients in Japan

47. Risk Factors Associated with Development and Persistence of Long COVID: A Cross-Sectional Study

50. Smoking and severe illness in hospitalized COVID-19 patients in Japan.

Catalog

Books, media, physical & digital resources